Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Operating Leases (2019 - 2024)

Firefly Neuroscience has reported Operating Leases over the past 6 years, most recently at $39610.0 for Q2 2024.

  • Quarterly results put Operating Leases at $39610.0 for Q2 2024, down 79.23% from a year ago — trailing twelve months through Jun 2024 was $39610.0 (down 79.23% YoY), and the annual figure for FY2023 was $136652.0, down 55.02%.
  • Operating Leases for Q2 2024 was $39610.0 at Firefly Neuroscience, down from $136652.0 in the prior quarter.
  • Over the last five years, Operating Leases for AIFF hit a ceiling of $605316.0 in Q2 2022 and a floor of $18363.0 in Q1 2020.
  • Median Operating Leases over the past 5 years was $288842.0 (2021), compared with a mean of $284163.3.
  • Biggest five-year swings in Operating Leases: tumbled 85.26% in 2020 and later skyrocketed 2407.79% in 2022.
  • Firefly Neuroscience's Operating Leases stood at $18363.0 in 2020, then surged by 2661.64% to $507120.0 in 2021, then crashed by 40.1% to $303778.0 in 2022, then tumbled by 55.02% to $136652.0 in 2023, then tumbled by 71.01% to $39610.0 in 2024.
  • The last three reported values for Operating Leases were $39610.0 (Q2 2024), $136652.0 (Q4 2023), and $353485.0 (Q3 2023) per Business Quant data.